arrow
S

Siri Lillegraven

Diakonhjemmet Hospital
H指数:26
被引数:2,358

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The association between systemic inflammation as measured by calprotectin and autoantibody load in rheumatoid arthritis

通过钙卫蛋白测量的系统性炎症与类风湿关节炎中自身抗体负荷的关联

2026-10-030
OAAI
Moving towards optimized treatment for children and adolescents with juvenile idiopathic arthritis in sustained remission randomized to continue stable treatment, methotrexate withdrawal or tumor necrosis factor inhibitor withdrawal: study protocol for the Norwegian multi-center MOVE-JIA trial

挪威多中心MOVE-JIA试验研究方案:针对持续缓解的幼年特发性关节炎儿童和青少年,比较继续稳定治疗、甲氨蝶呤撤药或肿瘤坏死因子抑制剂撤药优化治疗方案

2026-02-170
PRE
A DNA methylation-based algorithm for diagnosing rheumatoid arthritis

一种基于DNA甲基化的类风湿关节炎诊断算法

2025-10-190
OAAI
Recognition of Glycine Versus Nonglycine Citrulline Motifs Dictating the HLA Class II Association of Anticitrullinated Protein Antibodies: Insights From Autoantibody Profiling of 6,900 Scandinavian Patients With Rheumatoid Arthritis

识别甘氨酸与瓜氨酸基序对决定抗瓜氨酸蛋白抗体与HLA II类分子结合的影响:来自对6,900名斯堪的纳维亚类风湿关节炎患者自身抗体谱分析的研究启示

2025-04-300
OAAI
Development of machine learning models for predicting non-remission in early RA highlights the robust predictive importance of the RAID score-evidence from the ARCTIC study

用于预测早期RA未缓解的机器学习模型的开发突出了RAID评分的强大预测重要性-来自北极研究的证据

2025-02-120
OAAI
CLINICAL AND LABORATORY EXAMINATIONS THE FIRST 3 MONTHS PREDICT REMISSION AT 6 AND 12 MONTHS; RESULTS FROM A COLLABORATIVE STUDY ON TWO NORWEGIAN COHORTS OF EARLY OR ESTABLISHED RHEUMATOID ARTHRITIS

临床和实验室检查:前3个月预测6个月和12个月的缓解情况;来自一项关于挪威两个早期或晚期类风湿关节炎队列的协作研究

2024-06-010
PRE
ANTI-TYPE II COLLAGEN ANTIBODIES ASSOCIATE WITH HIGH LEVELS OF INFLAMMATION AT DIAGNOSIS BUT WITH GOOD CLINICAL OUTCOME - A STUDY BASED ON THE NORWEGIAN EARLY RHEUMATOID ARTHRITIS ARCTIC COHORT

抗II型胶原抗体与诊断时的高炎症水平相关,但与良好的临床结局相关——一项基于挪威早期类风湿关节炎北极队列的研究

2024-06-010
PRE
3-YEAR RESULTS OF TAPERING TNFi TO WITHDRAWAL COMPARED TO STABLE TNFi AMONG RHEUMATOID ARTHRITIS PATIENTS IN SUSTAINED REMISSION: A MULTICENTER RANDOMIZED TRIAL

3年随访结果:在持续缓解的类风湿关节炎患者中,将TNFi剂量递减至停药与维持稳定TNFi剂量进行比较:一项多中心随机试验

2024-06-010
PRE
Effects of tapering conventional synthetic disease-modifying antirheumatic drugs to drug-free remission versus stable treatment in rheumatoid arthritis (ARCTIC REWIND): 3-year results from an open-label, randomised controlled, non-inferiority trial
2024-05-011
PRE
Effect of Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Disease Flares in Patients With Rheumatoid Arthritis in Remission The ARCTIC REWIND Randomized Clinical Trial
2021-05-0425
OA